| David I Becker, MD | |
|
1493 Cambridge St, Cha - Surgery - Cambridge Campus, Cambridge, MA 02139-1047 | |
| (617) 665-2555 | |
| (617) 665-3598 |
| Full Name | David I Becker |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 34 Years |
| Location | 1493 Cambridge St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164515151 | NPI | - | NPPES |
| 0124338 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 207526 (Massachusetts) | Secondary |
| 208C00000X | Colon & Rectal Surgery | 207526 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cambridge Health Alliance | Cambridge, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cambridge Public Health Commission | 8921910894 | 536 |
News Archive
The University HealthSystem Consortium today announced that it has awarded a 3-year single-source agreement to Ascent, a leader in health care resource sustainability. The agreement, which has 2 optional 1-year renewal periods, became effective on July 1, 2010. Under the contract, Ascent will offer single-use device reprocessing programs to UHC's 107 academic medical centers and 233 affiliated hospitals.
Learning to crawl comes naturally for most infants, but those with cerebral palsy lack the muscle strength and coordination to perform the 25 individual movements required for crawling. With a $1.135 million, three-year grant from the National Science Foundation's National Robotics Initiative, University of Oklahoma researchers from the Norman and Health Sciences Center campuses are combining robotics, machine learning and brain imaging to assist infants with CP with the challenging, life-altering skill.
4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced positive topline data from its Phase II SAPHIRE trial with resminostat, its oral pan HDAC inhibitor, in patients with relapsed/refractory Hodgkin's Lymphoma.
If success is one per cent inspiration and ninety-nine percent perspiration, then it might follow that the Hyperhidrosis sufferer should have no trouble gaining employment. Not so fast.
› Verified 4 days ago
| Entity Name | Northeast Medical Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235147760 PECOS PAC ID: 2365405024 Enrollment ID: O20050111000265 |
News Archive
The University HealthSystem Consortium today announced that it has awarded a 3-year single-source agreement to Ascent, a leader in health care resource sustainability. The agreement, which has 2 optional 1-year renewal periods, became effective on July 1, 2010. Under the contract, Ascent will offer single-use device reprocessing programs to UHC's 107 academic medical centers and 233 affiliated hospitals.
Learning to crawl comes naturally for most infants, but those with cerebral palsy lack the muscle strength and coordination to perform the 25 individual movements required for crawling. With a $1.135 million, three-year grant from the National Science Foundation's National Robotics Initiative, University of Oklahoma researchers from the Norman and Health Sciences Center campuses are combining robotics, machine learning and brain imaging to assist infants with CP with the challenging, life-altering skill.
4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced positive topline data from its Phase II SAPHIRE trial with resminostat, its oral pan HDAC inhibitor, in patients with relapsed/refractory Hodgkin's Lymphoma.
If success is one per cent inspiration and ninety-nine percent perspiration, then it might follow that the Hyperhidrosis sufferer should have no trouble gaining employment. Not so fast.
› Verified 4 days ago
| Entity Name | Cambridge Public Health Commission |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932313228 PECOS PAC ID: 8921910894 Enrollment ID: O20050808000725 |
News Archive
The University HealthSystem Consortium today announced that it has awarded a 3-year single-source agreement to Ascent, a leader in health care resource sustainability. The agreement, which has 2 optional 1-year renewal periods, became effective on July 1, 2010. Under the contract, Ascent will offer single-use device reprocessing programs to UHC's 107 academic medical centers and 233 affiliated hospitals.
Learning to crawl comes naturally for most infants, but those with cerebral palsy lack the muscle strength and coordination to perform the 25 individual movements required for crawling. With a $1.135 million, three-year grant from the National Science Foundation's National Robotics Initiative, University of Oklahoma researchers from the Norman and Health Sciences Center campuses are combining robotics, machine learning and brain imaging to assist infants with CP with the challenging, life-altering skill.
4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced positive topline data from its Phase II SAPHIRE trial with resminostat, its oral pan HDAC inhibitor, in patients with relapsed/refractory Hodgkin's Lymphoma.
If success is one per cent inspiration and ninety-nine percent perspiration, then it might follow that the Hyperhidrosis sufferer should have no trouble gaining employment. Not so fast.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David I Becker, MD 1493 Cambridge St, Cha - Surgery - Cambridge Campus, Cambridge, MA 02139-1047 Ph: (617) 665-2555 | David I Becker, MD 1493 Cambridge St, Cha - Surgery - Cambridge Campus, Cambridge, MA 02139-1047 Ph: (617) 665-2555 |
News Archive
The University HealthSystem Consortium today announced that it has awarded a 3-year single-source agreement to Ascent, a leader in health care resource sustainability. The agreement, which has 2 optional 1-year renewal periods, became effective on July 1, 2010. Under the contract, Ascent will offer single-use device reprocessing programs to UHC's 107 academic medical centers and 233 affiliated hospitals.
Learning to crawl comes naturally for most infants, but those with cerebral palsy lack the muscle strength and coordination to perform the 25 individual movements required for crawling. With a $1.135 million, three-year grant from the National Science Foundation's National Robotics Initiative, University of Oklahoma researchers from the Norman and Health Sciences Center campuses are combining robotics, machine learning and brain imaging to assist infants with CP with the challenging, life-altering skill.
4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced positive topline data from its Phase II SAPHIRE trial with resminostat, its oral pan HDAC inhibitor, in patients with relapsed/refractory Hodgkin's Lymphoma.
If success is one per cent inspiration and ninety-nine percent perspiration, then it might follow that the Hyperhidrosis sufferer should have no trouble gaining employment. Not so fast.
› Verified 4 days ago